[
  {
    "question": "Female ataxia for one year, and mild cognitive impairment, ;MRI showed cerebellar peduncle hyperintensities no further details",
    "option_a": "(Paraneoplastic) is correct given the patient\u2019s demographics (female), chronicity of ataxia, associated mild cognitive impairment, and the MRI finding of cerebellar peduncle hyperintensities. Option B (Premutation fragile X syndrome, referring to FXTAS) is less likely as FXTAS predominantly affects older males with prominent intention tremor. Option C (Benign MS) is not supported by the chronic, steadily progressive course and the isolated peduncular imaging changes.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Other/Unclassified",
    "explanation": "Paraneoplastic cerebellar degeneration is an immune-mediated neurological syndrome in which the body's immune response to a malignancy inadvertently attacks cerebellar neurons, leading to ataxia and sometimes cognitive impairment. Antibodies produced against tumor antigens cross-react with antigens in the cerebellum (often targeting Purkinje cells), causing neuronal loss. The process is typically subacute to chronic and may be the first sign of an occult malignancy. The patient\u2019s presentation of progressive ataxia over one year accompanied by mild cognitive deficits, along with MRI findings of cerebellar peduncle hyperintensities, aligns with paraneoplastic cerebellar degeneration. This condition is more frequently seen in association with cancers (such as breast, ovarian, or small cell lung cancer) and may present even before the malignancy is diagnosed. Evaluation includes testing for specific paraneoplastic antibodies (e.g., anti-Yo, anti-Hu) and comprehensive cancer screening (CT, PET scans). Differential diagnoses include FXTAS, which is more common in older males and typically features tremor and more prominent white matter changes in the middle cerebellar peduncles, and multiple sclerosis, which generally presents with relapsing-remitting episodes and disseminated lesions in time and space. Management focuses on treating the underlying malignancy and suppressing the immune-mediated neuronal injury. First-line strategies include immunotherapy (corticosteroids, intravenous immunoglobulin, or plasmapheresis) alongside oncologic treatments such as surgery, chemotherapy, or radiation. In pregnant or lactating patients, treatment decisions must balance maternal benefits and fetal safety, with corticosteroids generally considered relatively safe while many immunotherapeutic agents require caution. Option A (Paraneoplastic) is correct given the patient\u2019s demographics (female), chronicity of ataxia, associated mild cognitive impairment, and the MRI finding of cerebellar peduncle hyperintensities. Option B (Premutation fragile X syndrome, referring to FXTAS) is less likely as FXTAS predominantly affects older males with prominent intention tremor. Option C (Benign MS) is not supported by the chronic, steadily progressive course and the isolated peduncular imaging changes. 1) Always consider paraneoplastic syndromes in patients with subacute or chronic ataxia and cognitive changes, especially in older females. 2) Paraneoplastic cerebellar degeneration can predate a cancer diagnosis by months to years, warranting thorough screening. Recent research has identified more specific autoantibodies associated with paraneoplastic cerebellar degeneration, improving early diagnosis. Updated guidelines advocate for a combined immunotherapy and oncologic treatment approach, emphasizing early intervention to preserve neurological function.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "Male came with 40 times unilateral pain on forehead lasting for 1 min with conjunctival injection and tearing no trigger what tx.",
    "option_a": "Lamotrigine",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Other/Unclassified",
    "explanation": "The described headache syndrome falls within the spectrum of trigeminal autonomic cephalalgias (TACs), specifically aligning with SUNCT (Short-lasting Unilateral Neuralgiform headache attacks with Conjunctival injection and Tearing). SUNCT is believed to result from hypothalamic dysfunction and abnormal activation of the trigeminal autonomic reflex. This leads to rapid, severe unilateral headache attacks accompanied by ipsilateral cranial autonomic symptoms such as lacrimation and conjunctival injection. The patient\u2019s presentation of 40 episodes of unilateral forehead pain, each lasting about one minute, coupled with conjunctival injection and tearing, is classic for SUNCT. The extremely short duration and high frequency help differentiate it from other TACs such as cluster headache (which typically lasts 15\u2013180 minutes) and paroxysmal hemicrania (which usually responds dramatically to indomethacin). Diagnosis is clinical. It involves a careful history focusing on headache duration, frequency, and associated symptoms. Differential diagnoses include cluster headache and paroxysmal hemicrania. Cluster headaches have longer attack durations and a circadian pattern, while paroxysmal hemicrania is typically exquisitely responsive to indomethacin. First-line treatment for SUNCT is lamotrigine, which has shown efficacy in reducing attack frequency and severity. Second-line agents may include topiramate or gabapentin. In pregnant or lactating patients, lamotrigine is generally considered one of the safer antiepileptics; however, close monitoring is essential due to potential changes in drug metabolism during pregnancy. Option A (Lamotrigine) is correct because multiple clinical studies and guidelines endorse its use as the first-line treatment for SUNCT. Other options, though not listed here, would either not target the underlying pathophysiology or lack evidence in this specific syndrome. 1) SUNCT attacks are very brief but can be very frequent, distinguishing them from other TACs. 2) A robust response to lamotrigine supports the diagnosis of SUNCT and can be used as both treatment and a diagnostic clue. Recent studies confirm the benefit of lamotrigine in reducing the frequency and intensity of SUNCT attacks. Updated headache management guidelines continue to recommend lamotrigine as first-line therapy, and ongoing research is focused on the neurobiological mechanisms behind TACs to develop more targeted treatments.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "5 yr old male with developmental delay, showing bilateral symmetrical putamin and GP signal changes",
    "option_a": "(Leigh disease) is correct because the bilateral, symmetrical involvement of the putamen and globus pallidus on MRI in a 5\u2010year\u2010old with developmental delay is classic for this condition. Option B (MELAS) is incorrect as MELAS usually presents with stroke\u2010like episodes and cortical/subcortical lesions rather than isolated, symmetric basal ganglia changes. Option C (MNGIE) is incorrect because MNGIE is characterized by gastrointestinal dysmotility, peripheral neuropathy, and diffuse white matter changes, not the specific basal ganglia findings seen here.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Other/Unclassified",
    "explanation": "Leigh disease is a mitochondrial encephalomyopathy often presenting in infancy or early childhood. It is characterized by a failure of energy metabolism in the central nervous system, leading to progressive neurological deterioration. It results from genetic defects\u2014either in mitochondrial DNA or nuclear genes\u2014that impair oxidative phosphorylation. The resulting energy deficit causes neuronal degeneration and necrosis, particularly in regions with high metabolic demand such as the basal ganglia (i.e., the putamen and globus pallidus), leading to the symmetrical signal changes seen on MRI. Children with Leigh disease typically present with developmental delay, hypotonia, and diverse neurological deficits. The symmetric signal abnormalities in the basal ganglia correlate with clinical signs of movement disorders and neurologic regression, often accompanied by lactic acidosis. Diagnosis is based on a combination of clinical findings, characteristic neuroimaging features (symmetric lesions in basal ganglia/brainstem), metabolic studies (elevated lactate levels), and genetic testing. Differential diagnoses include other mitochondrial disorders such as MELAS, which usually presents with stroke\u2010like episodes and cortical involvement, and metabolic disorders affecting the basal ganglia. MRI findings along with the clinical age and presentation help differentiate these conditions. There is no definitive cure for Leigh disease. Management is primarily supportive and symptomatic. First-line interventions include nutritional support, mitochondrial cocktail supplementation (e.g., coenzyme Q10, thiamine, vitamin B complexes), and interventions to control metabolic acidosis. In the setting of pregnancy or lactation (when relevant for maternal carriers), genetic counseling and careful evaluation of drug safety profiles are paramount. Advanced research is exploring targeted therapies, but none has yet reached standard clinical practice. Option A (Leigh disease) is correct because the bilateral, symmetrical involvement of the putamen and globus pallidus on MRI in a 5\u2010year\u2010old with developmental delay is classic for this condition. Option B (MELAS) is incorrect as MELAS usually presents with stroke\u2010like episodes and cortical/subcortical lesions rather than isolated, symmetric basal ganglia changes. Option C (MNGIE) is incorrect because MNGIE is characterized by gastrointestinal dysmotility, peripheral neuropathy, and diffuse white matter changes, not the specific basal ganglia findings seen here. 1. Symmetric basal ganglia lesions on MRI in a pediatric patient with developmental delay strongly suggest a mitochondrial disorder such as Leigh disease. 2. Elevated lactate levels and mitochondrial dysfunction are key elements in the pathogenesis of Leigh disease. Recent studies emphasize the value of combining metabolic, neuroimaging, and genetic testing to secure a diagnosis. Although therapeutic options remain supportive, ongoing clinical trials are exploring mitochondrial-directed therapies and gene-based interventions.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "Scenario suggestive of wilson, with KF ring, and MRI features what is next step to confirm dx",
    "option_a": "",
    "option_b": "",
    "option_c": "(Serum ceruloplasmin measurement) is correct because it is a sensitive, noninvasive test that helps confirm the diagnosis in a patient with clinical features and KF rings. Option A (Liver biopsy) is more invasive and typically reserved for cases where noninvasive tests yield inconclusive results. Option B (Genetic test) is not used as the initial confirmatory test due to variability in mutations and availability.",
    "option_d": "",
    "option_e": "",
    "correct_answer": "c",
    "subspecialty": "Other/Unclassified",
    "explanation": "Wilson disease is an autosomal recessive disorder of copper metabolism. It leads to copper accumulation in various tissues, including the liver, brain, and eyes. Mutations in the ATP7B gene impair excretion of copper into bile, resulting in toxic accumulation. This excess copper deposits in the liver, causing hepatic dysfunction, and in the brain, particularly in the basal ganglia, leading to neurological deficits. Kayser-Fleischer (KF) rings arise from copper deposition in Descemet\u2019s membrane in the cornea. Patients may present with hepatic, neurological, and psychiatric manifestations. The presence of KF rings and typical MRI changes (often in the basal ganglia) in a young patient raises high clinical suspicion for Wilson disease. After clinical suspicion (including KF rings and supportive imaging), the next step is to measure serum ceruloplasmin. Differential diagnoses include other causes of movement disorders and metabolic liver diseases. In cases of uncertainty, 24-hour urinary copper quantification, liver biopsy for copper quantification, and genetic testing may follow. First-line treatment involves copper chelation therapy with agents such as D-penicillamine or trientine. Zinc therapy, which blocks copper absorption, is an alternative or adjunct treatment. Pregnancy and lactation require careful management: penicillamine is categorized as pregnancy category D but may be used when benefits outweigh risks; zinc is generally considered safer, and dose adjustments or close monitoring is recommended. Lifelong treatment is necessary to prevent disease progression. Option C (Serum ceruloplasmin measurement) is correct because it is a sensitive, noninvasive test that helps confirm the diagnosis in a patient with clinical features and KF rings. Option A (Liver biopsy) is more invasive and typically reserved for cases where noninvasive tests yield inconclusive results. Option B (Genetic test) is not used as the initial confirmatory test due to variability in mutations and availability. 1. Kayser-Fleischer rings are a critical diagnostic clue in Wilson disease with neurological involvement. 2. Low serum ceruloplasmin levels (<20 mg/dL) strongly support the diagnosis, though they must be interpreted in context. Current guidelines advocate for serum ceruloplasmin as a first-line diagnostic test. New advances in genetic screening and the development of noninvasive liver copper quantification techniques are being actively researched, but biochemical assays remain the clinical standard.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "What suggest central nystagmus",
    "option_a": "(Lack of latency) is correct since central nystagmus typically begins immediately upon provocative testing, without the delay seen in peripheral disorders. Other features such as improvement with visual fixation might point to a peripheral origin.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "a",
    "subspecialty": "Other/Unclassified",
    "explanation": "Nystagmus is an involuntary, rhythmic oscillation of the eyes. It can be classified as arising from either peripheral vestibular dysfunction or central nervous system lesions affecting ocular motor control. Central nystagmus is due to lesions in the brainstem or cerebellum that affect the neural pathways controlling eye movements. The absence of a latency period is indicative of direct involvement of central pathways, in contrast to peripheral vestibular nystagmus which typically demonstrates a short latency period before onset. Patients with central nystagmus may present with additional neurological deficits such as dysmetria or ataxia, depending on the lesion location. In contrast, peripheral nystagmus (often seen in vestibular disorders) may demonstrate a brief latency and is usually associated with vertigo and auditory symptoms. The diagnostic evaluation includes a detailed clinical examination focusing on the characteristics of the nystagmus, neurologic assessment, and neuroimaging (typically MRI) to evaluate for brainstem or cerebellar lesions. Differential diagnoses include benign paroxysmal positional vertigo (BPPV) for peripheral causes and multiple sclerosis or stroke for central lesions. Management depends on the underlying etiology. For central causes, appropriate neuroimaging and referral to neurology are warranted. Treatment of the underlying central lesion is crucial. In pregnant or lactating patients, imaging modalities such as MRI are generally considered safe, though contrast use should be judicious. Option A (Lack of latency) is correct since central nystagmus typically begins immediately upon provocative testing, without the delay seen in peripheral disorders. Other features such as improvement with visual fixation might point to a peripheral origin. 1. An immediate onset of nystagmus without latency strongly suggests a central origin. 2. Central nystagmus is often accompanied by other neurological signs that are absent in peripheral vestibular nystagmus. Recent clinical studies and expert consensus continue to reinforce the importance of detailed bedside eye movement examinations for differentiating central from peripheral causes, with neuroimaging playing a key supportive role.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "Light near dissociation most commonly described in?? Note; all choices can come with it (but they want then commonest on)",
    "option_a": "(Paranoid syndrome) is incorrect as psychiatric conditions do not typically produce the specific light",
    "option_b": "(Neurosyphilis) is correct because it is the classic cause of Argyll Robertson pupils, which demonstrate light",
    "option_c": "(AIDS pupil) is incorrect since HIV/AIDS more commonly leads to varied pupillary responses secondary to opportunistic infections or medication effects, rather than the specific finding of light",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Other/Unclassified",
    "explanation": "Light-near dissociation refers to a condition where the pupils do not constrict in response to light, yet constrict normally during accommodation. This dissociation is most famously associated with the Argyll Robertson pupil. The phenomenon is generally due to lesions affecting the pretectal area of the midbrain. In neurosyphilis, the involvement of these midbrain structures leads to the classic Argyll Robertson pupil, where the pupillary light reflex is abolished while the accommodation reflex is preserved. Clinically, patients with neurosyphilis and the Argyll Robertson pupil may also present with other signs of syphilitic involvement, such as sensory ataxia or positive serologic tests for syphilis. This pupillary abnormality is less commonly seen in purely psychiatric conditions or HIV-related neuropathies. When light-near dissociation is detected, further evaluation including serologic testing for syphilis (VDRL/RPR and confirmatory treponemal tests) is indicated. Differential diagnoses include Parinaud\u2019s syndrome, diabetes-related autonomic neuropathy, and midbrain lesions from other causes. The complete clinical picture assists in narrowing the diagnosis. For neurosyphilis, the first-line treatment is intravenous penicillin G. In pregnant or lactating patients, penicillin remains the treatment of choice as it is effective and safe, with careful monitoring. Alternative regimens for those allergic to penicillin require desensitization due to the efficacy of penicillin in treating neurosyphilis. Option A (Paranoid syndrome) is incorrect as psychiatric conditions do not typically produce the specific light-near dissociation seen with Argyll Robertson pupils. Option B (Neurosyphilis) is correct because it is the classic cause of Argyll Robertson pupils, which demonstrate light-near dissociation. Option C (AIDS pupil) is incorrect since HIV/AIDS more commonly leads to varied pupillary responses secondary to opportunistic infections or medication effects, rather than the specific finding of light-near dissociation. 1. The presence of light-near dissociation (Argyll Robertson pupil) is highly suggestive of neurosyphilis, particularly in the context of other neurological or systemic signs. 2. A thorough serologic evaluation for syphilis is indicated when this pupillary abnormality is observed. Guidelines from neurology and infectious disease societies continue to recognize neurosyphilis as the most common etiology for classical Argyll Robertson pupils. Current research emphasizes the importance of early recognition and treatment of neurosyphilis to prevent irreversible neurological damage.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "Pendular hallucination came with?",
    "option_a": "",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "1",
    "subspecialty": "Other/Unclassified",
    "explanation": "Pendular (or peduncular) hallucinations refer to a specific type of visual hallucination that is often linked to brainstem pathology. The core concept is that lesions in specific midbrain regions\u2014especially those involved in ocular motor control and visual processing\u2014can produce vivid, sometimes oscillatory, hallucinatory experiences. Lesions in the dorsal midbrain, which includes structures such as the superior colliculus and adjacent areas involved in visual integration, can disrupt normal processing. This disruption may lead to abnormal signaling that manifests as pendular hallucinations. The phenomenon is often discussed in the context of peduncular hallucinosis, wherein damage to these midbrain structures results in vivid, unformed or minimally formed visual hallucinations due to a loss of normal inhibitory control. Patients with midbrain lesions may present with other signs such as vertical gaze palsy, pupillary abnormalities, or features of Parinaud\u2019s syndrome. The presence of a pendular type of hallucination in a patient should prompt evaluation of midbrain function and associated ocular motor findings. The evaluation typically includes detailed neurological examination and neuroimaging\u2014preferably MRI\u2014to identify midbrain lesions. Differential diagnoses include complex visual hallucinations from cortical involvement (seen in Charles Bonnet syndrome or Lewy Body dementia) and hallucinations related to psychiatric disorders, which often have different phenomenology and associated symptoms. Management involves addressing the underlying cause. For instance, if the lesion is vascular, appropriate stroke management is indicated; if neoplastic, neurosurgical consultation is required. Symptomatic treatments may be considered for hallucinations. In cases where lesions are secondary to inflammatory or demyelinating processes, corticosteroids or immunomodulatory therapies might be used. Pregnancy and lactation considerations depend on the underlying etiology and treatment modality; MRI is generally safe during pregnancy when necessary, and treatment choices should balance maternal benefit with fetal safety. Option 1 (Midbrain lesion) is correct because it accurately identifies the location classically associated with pendular hallucinations. The other options implying none or alternative locations (such as cortical lesions, which typically cause more complex hallucinations) are inconsistent with the established clinical and neuroanatomical evidence. 1. Pendular hallucinations are a hallmark of dorsal midbrain or peduncular lesions and often occur with ocular motor disturbances. 2. A detailed neuro-ophthalmologic examination can provide important clues to localize the lesion. 3. MRI of the brain is the imaging modality of choice to assess midbrain pathology. Recent neuroimaging studies continue to support the link between dorsal midbrain lesions and the occurrence of peduncular hallucinosis. Updated reviews emphasize the role of detailed clinical examination alongside high-resolution MRI to pinpoint these lesions, ensuring appropriate and timely management.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "Pt came with headache / vomiting/ fever and nuckal regidity, 2 weeks back she had decompressive craniotomy due to chairi. What is the organism??",
    "option_a": "staph",
    "option_b": "Strept",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Other/Unclassified",
    "explanation": "Post-operative meningitis is a serious complication following neurosurgical procedures. The core understanding is that breaches in the cranial barrier during procedures such as decompressive craniotomy can predispose patients to infectious complications. Surgical procedures on the brain disrupt the protective layers (dura, skull) and can introduce pathogens. Staphylococcus species\u2014especially Staphylococcus aureus and coagulase-negative staphylococci (e.g., S. epidermidis)\u2014are commonly implicated because they are part of the skin flora and can contaminate the surgical site. These bacteria can incite an inflammatory response in the meninges leading to meningitis. The clinical presentation, including headache, vomiting, fever, and nuchal rigidity, is classic for meningitis. The temporal relationship (postoperative period of around two weeks) further supports an infection related to the surgical intervention. It is important to correlate clinical findings with recent neurosurgical history when evaluating such cases. Diagnosis involves lumbar puncture with cerebrospinal fluid (CSF) analysis including cell counts, protein, glucose, Gram stain, and culture. Neuroimaging may be used to rule out abscess formation or other complications. The differential diagnosis includes nosocomial meningitis due to other gram-positive organisms, gram-negative bacilli, and sometimes fungal etiologies depending on the clinical context. The management is guided by cultures and sensitivity results. Empirical treatment typically covers both gram-positive cocci (including MRSA) and gram-negative organisms. First-line treatment often includes vancomycin combined with a third- or fourth-generation cephalosporin or another agent with good CNS penetration. In pregnant or lactating patients, careful antibiotic selection is needed to balance efficacy and fetal/neonatal safety; cephalosporins are generally considered safe, and vancomycin can be used when benefits outweigh risks. Option A (Staph) is correct because Staphylococcus species are the most common organisms causing postoperative meningitis after cranial surgeries. Option B (Streptococcus), while a known pathogen for community-acquired meningitis, is less commonly associated with neurosurgical infections, making it an incorrect choice in this scenario. 1. Always consider the surgical history when evaluating meningitis, as postoperative infections can present within weeks of surgery. 2. Staphylococcus aureus and coagulase-negative staphylococci are the predominant pathogens in post-neurosurgical meningitis. 3. Early and appropriate empirical antibiotic therapy is critical for improving outcomes in these patients. Recent guidelines from infectious disease societies support the use of broad-spectrum antibiotics tailored to cover common postoperative pathogens. Ongoing research emphasizes the importance of infection control measures in the operating room and postoperatively to minimize these risks.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "What is the prevention of postherpatic neuralgia??",
    "option_a": "Antiviral",
    "option_b": "Topical lidocain",
    "option_c": "Steroid",
    "option_d": "Antiviral ?",
    "option_e": "",
    "correct_answer": "D",
    "subspecialty": "Other/Unclassified",
    "explanation": "Postherpetic neuralgia (PHN) is a chronic neuropathic pain syndrome that can occur as a complication of herpes zoster (shingles). The primary prevention strategy focuses on early intervention during the acute phase of the viral infection. Herpes zoster results from reactivation of the varicella-zoster virus (VZV) in a dorsal root ganglion, leading to inflammation and nerve damage. This nerve injury is believed to contribute to the development of long-term neuropathic pain (PHN). Early antiviral therapy helps control viral replication, potentially reducing nerve damage and the likelihood of PHN. Patients with herpes zoster typically present with a painful, vesicular rash in a dermatomal distribution. Prompt treatment, ideally within 72 hours of rash onset, has been shown to decrease the severity and duration of acute pain and may reduce the incidence of PHN. Other modalities like topical lidocaine are useful for symptomatic relief in established PHN but are not preventive. Diagnosis of herpes zoster is primarily clinical based on the characteristic rash and pain. Polymerase chain reaction (PCR) tests or direct fluorescent antibody tests can confirm the diagnosis in atypical cases. Differential diagnoses include herpes simplex infections and other causes of radicular pain. The first-line strategy for preventing PHN is early administration of antiviral medications such as acyclovir, valacyclovir, or famciclovir. These agents can help reduce viral replication and minimize nerve injury. While steroids have been studied as adjuncts, their role in preventing PHN is less clear and not routinely recommended as sole therapy. Topical agents, including lidocaine, are used for pain relief in established PHN rather than prevention. For pregnant and lactating patients, antiviral drugs like acyclovir are classified as relatively safe when used appropriately, but treatment decisions should be individualized based on risk\u2013benefit assessments. Option D, which indicates the use of an antiviral for the prevention of postherpetic neuralgia, is correct. Option A (antiviral) is essentially the same as D, indicating that early antiviral therapy is the best strategy for prevention. Options B (topical lidocaine) and C (steroid) are generally used for symptom control once PHN is established rather than for primary prevention of the condition. 1. Initiate antiviral therapy within 72 hours of rash onset to reduce the risk of PHN. 2. Early treatment not only alleviates acute symptoms but may also reduce long-term complications. 3. Adjunctive therapies are useful for ongoing pain management but do not substitute for early antiviral intervention. Recent clinical guidelines and systematic reviews continue to support the early use of antivirals in the management of herpes zoster to prevent PHN. Studies also explore the benefit of multimodal approaches; however, antivirals remain the cornerstone of PHN prevention.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "pt came with rt optic atrophy and left papilledema where is the localization of the mass ?",
    "option_a": "left frontal",
    "option_b": "Rt frontal",
    "option_c": "Left occipital",
    "option_d": "Rt occipital",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Other/Unclassified",
    "explanation": "Foster Kennedy syndrome is a well-recognized clinical entity in neurology. Its hallmark is the combination of ipsilateral optic atrophy and contralateral papilledema, typically caused by a frontal lobe mass\u2014most commonly an olfactory groove meningioma. The syndrome arises when a mass in one frontal lobe compresses the ipsilateral optic nerve, leading to optic atrophy, while simultaneously causing increased intracranial pressure (ICP). The increased ICP then causes papilledema in the contralateral eye. The discrepancy in findings (atrophy versus papilledema) is due to direct compressive damage on one side preventing the transmission of ICP-related changes. In this case, the patient has right optic atrophy and left papilledema. This exactly fits the classic description of Foster Kennedy syndrome, where the tumor is localized to the right frontal lobe. Other accompanying features may include anosmia on the affected side and personality changes. Neuroimaging with MRI is the investigation of choice to identify and localize the mass, assess its characteristics, and plan management. Differential diagnoses include other intracranial tumors such as gliomas that might present with raised ICP, but the specific combination of unilateral optic atrophy with contralateral papilledema is distinctive for Foster Kennedy syndrome. Management primarily involves neurosurgical resection of the mass. Adjuvant treatments (such as radiotherapy) may be considered based on the tumor type, size, and location. Preoperative corticosteroids can be used to reduce cerebral edema. In pregnant or lactating patients, imaging protocols and surgical planning must consider fetal safety; MRI without gadolinium is generally preferred, and timing of surgery is carefully planned based on gestational age and clinical urgency. Option B (Right frontal) is correct because it aligns with the clinical picture seen in Foster Kennedy syndrome\u2014right optic atrophy with contralateral (left) papilledema is typically due to a right-sided frontal mass. Option A (Left frontal) would imply ipsilateral signs on the left eye, while options C and D (occipital lesions) do not produce the characteristic findings seen in this syndrome. 1. Foster Kennedy syndrome is defined by the paradox of unilateral optic atrophy and contralateral papilledema. 2. A frontal lobe mass, most often an olfactory groove meningioma, is the prototypical cause. 3. Early identification and surgical management are key to preventing further vision loss and neurologic deterioration. Recent literature reinforces the classic description of Foster Kennedy syndrome. Advances in neuroimaging have improved early detection, and contemporary neurosurgical techniques offer better outcomes. Updated guidelines advocate for a multidisciplinary approach involving neurology, neuro-ophthalmology, and neurosurgery for optimal management.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "Long scenario pt with trigeminal neuralgia there is involvement of V1 which artery is do vascular compression?",
    "option_a": "represents the Superior Cerebellar Artery, this is consistent with the large body of clinical evidence. The SCA is recognized as the most common vessel to compress the trigeminal nerve, resulting in the pain syndrome seen in trigeminal neuralgia, including cases affecting V1.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Other/Unclassified",
    "explanation": "Trigeminal neuralgia is a neuropathic pain syndrome most commonly caused by vascular compression at the nerve\u2019s root entry zone. In most cases, the superior cerebellar artery (SCA) is the culprit, compressing the nerve which can affect any of its three divisions (V1, V2, or V3). Even though the syndrome classically involves the maxillary and mandibular divisions, involvement of V1 (ophthalmic) is possible under a broader compression. The pulsatile compression from the SCA leads to focal demyelination at the entry zone of the trigeminal nerve. This demyelination causes aberrant transmission and hyperexcitability that manifests as intense, shock-like pain paroxysms. The compression mechanism is well-documented, especially in cases that eventually require microvascular decompression. Patients with trigeminal neuralgia typically report brief, stabbing, and excruciating facial pain, often triggered by light touch, chewing, or even a breeze. Although involvement of V1 is less common, its presence alongside V2 or V3 symptoms reinforces the likelihood of a single vascular compression event affecting the proximal portion of the nerve. Diagnosis is primarily clinical; however, high-resolution MRI (with specific sequences such as FIESTA or CISS) is utilized to identify neurovascular conflicts. Differential diagnoses include multiple sclerosis (especially in younger patients), dental or sinus pathology, postherpetic neuralgia, and atypical facial pain. Initial treatment centers on pharmacotherapy, with carbamazepine as the first-line agent. Alternatives include oxcarbazepine. For patients who do not respond to medical management, surgical intervention (commonly microvascular decompression) is recommended. For pregnant patients, carbamazepine is associated with teratogenic risk and requires careful use or substitution with safer alternatives under specialist guidance. During lactation, clinicians must assess the balance between maternal benefit and potential neonatal exposure, often preferring the lowest effective doses and monitoring for adverse effects. Given that the marked answer is A, and assuming that option A represents the Superior Cerebellar Artery, this is consistent with the large body of clinical evidence. The SCA is recognized as the most common vessel to compress the trigeminal nerve, resulting in the pain syndrome seen in trigeminal neuralgia, including cases affecting V1. \u2022 High-resolution MRI is essential to visualize neurovascular compression in trigeminal neuralgia.\n\u2022 The superior cerebellar artery is the most frequent offending vessel.\n\u2022 In refractory cases, microvascular decompression offers prolonged relief.\n\u2022 Special considerations are needed for women who are pregnant or lactating when using first-line antiepileptic drugs. Recent studies continue to validate the efficacy of microvascular decompression in providing long-term pain relief. Updated guidelines emphasize careful patient selection and conservative management initially. There is also growing research into alternative pharmacotherapies in pregnancy to minimize fetal risk while controlling symptoms.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "Long scenario deafness visual issues myoclonus, and also came with stroke MERF. WHAT you will do??",
    "option_a": "NOTCH 3",
    "option_b": "Measure pyruvate / lactate",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Other/Unclassified",
    "explanation": "The clinical scenario describes a patient with a long history of sensorineural deafness, visual disturbances, myoclonus, and stroke-like episodes. This constellation of symptoms is highly suggestive of a mitochondrial disorder such as MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes) or features overlapping with MERRF (Myoclonic Epilepsy with Ragged Red Fibers). The appropriate next step is to evaluate for mitochondrial dysfunction by measuring lactate and pyruvate levels. Mitochondrial diseases arise from mutations in mitochondrial DNA, leading to impaired oxidative phosphorylation. This defect results in decreased energy production in high-demand tissues (brain, muscle, auditory, and visual systems) and subsequent accumulation of metabolic byproducts like lactate. The elevated lactate-to-pyruvate ratio is a biochemical hallmark of these disorders. The combination of deafness, visual problems, myoclonus, and stroke-like events aligns with the clinical picture of mitochondrial cytopathies. MELAS is particularly noted for stroke-like episodes and lactic acidosis, while MERRF is characterized by myoclonus, though it usually exhibits prominent myoclonic seizures and ragged red fibers on muscle biopsy. Differential diagnoses include mitochondrial disorders (MELAS/MERRF) versus other vasculopathies like CADASIL. CADASIL, associated with NOTCH3 mutations, more typically presents with migraine with aura, subcortical infarcts, and cognitive decline without the pronounced sensorineural deafness and myoclonus seen in mitochondrial disease. Therefore, the measurement of pyruvate and lactate levels is warranted as an initial diagnostic step to screen for mitochondrial dysfunction. Management of mitochondrial disorders is largely supportive. Acute management of stroke-like episodes may include intravenous arginine, and chronic strategies may involve supplementation with agents such as Coenzyme Q10, L-carnitine, or other antioxidants to support mitochondrial function. For pregnant or lactating patients, careful risk\u2013benefit analysis of all medications is essential, given the maternal inheritance pattern of mitochondrial DNA mutations. Close monitoring during pregnancy and avoidance of mitochondrial toxins are recommended per current guidelines. Option A (NOTCH 3) would be appropriate if the clinical picture suggested CADASIL; however, the features of sensorineural hearing loss and myoclonus are atypical for CADASIL. Option B (Measure pyruvate/lactate) directly addresses the suspicion of a mitochondrial disorder by evaluating the metabolic signature typical in conditions like MELAS. The absence of other options further supports that B is the correct choice. When encountering patients with stroke-like episodes in the absence of traditional vascular risk factors, accompanied by multisystem involvement such as hearing loss and myoclonus, always consider a mitochondrial etiology. Early measurement of serum lactate and pyruvate can be pivotal in guiding the diagnosis. Recent research supports the use of metabolic markers (like an elevated lactate/pyruvate ratio) as a sensitive screening tool for mitochondrial disorders. Genetic testing for common mtDNA mutations (e.g., the m.3243A>G mutation in MELAS) is also standard following abnormal biochemical findings. Updated guidelines emphasize individualized management, especially in the context of pregnancy and lactation, to optimize maternal and fetal outcomes while minimizing exacerbation of mitochondrial dysfunction.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "What support central nystagmus rather than peripheral nystagmus?",
    "option_a": "Absence of latency",
    "option_b": "sever nausea and vomiting",
    "option_c": "disappear and loss with visual fixation \u0645\u0648 \u0645\u062a\u0627\u0643\u062f\u0629 \u0645\u0646 \u0646\u0635 \u0647\u0627\u0644\u0627\u062e\u062a\u064a",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Other/Unclassified",
    "explanation": "Central vs peripheral nystagmus is differentiated by several characteristics. Central nystagmus (due to brainstem or cerebellar lesions) typically lacks a latency period on positional changes, is not suppressed by visual fixation, and may present with other neurological deficits. In contrast, peripheral nystagmus (due to inner ear or vestibular nerve disorders) generally shows a short latency and is reduced by visual fixation. Peripheral nystagmus arises from asymmetry in vestibular input due to labyrinthine or vestibular nerve dysfunction, often producing a delayed nystagmus after head movement. Central nystagmus is due to lesions in the cerebellum or brainstem which disrupt normal ocular motor control mechanisms, leading to an immediate (absence of latency) onset of nystagmus upon positional change. Patients with central lesions may exhibit additional neurologic signs such as ataxia, dysarthria, diplopia, or other focal deficits, while isolated peripheral vertigo commonly presents with marked nausea, vomiting, and tinnitus. In central causes, the nystagmus is less likely to be suppressed by visual fixation, reinforcing the suspicion of a central process. The evaluation involves a focused neurologic exam, including the HINTS (Head Impulse, Nystagmus, Test of Skew) protocol. An immediate onset nystagmus without latency\u2014especially if it persists with visual fixation\u2014points toward a central lesion. Neuroimaging (MRI) is typically indicated if central features are suspected. For suspected central causes of nystagmus, timely neuroimaging (preferably MRI) is essential to rule out serious conditions such as stroke. Management is guided by the underlying etiology. In pregnancy or lactation, MRI without contrast is generally considered safe, and if CT scanning is needed for acute stroke evaluation, appropriate shielding and risk-benefit discussions should be undertaken. Option A (Absence of latency) is the feature supporting central nystagmus because central lesions typically provoke an immediate nystagmus without the delay seen in peripheral causes. Option B (severe nausea and vomiting) is more characteristic of peripheral vertigo. Option C (disappear and loss with visual fixation) describes a feature typical of peripheral nystagmus rather than central, as central nystagmus usually does not diminish with visual fixation. A key clinical pearl is that central nystagmus does not show the latency and fixation suppression seen in peripheral nystagmus. An absence of latency combined with other neurological findings should prompt urgent neuroimaging to rule out central pathology such as cerebellar infarction. Recent studies and clinical guidelines reinforce that features like an immediate onset of nystagmus and lack of improvement with fixation are red flags for central lesions. This evidence supports the use of detailed bedside examinations, such as HINTS, to differentiate central from peripheral causes, ensuring timely imaging and intervention, particularly in high-risk populations.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "pt had left eye heterotropia and skew, pt tilt to the rt where is the lesion?",
    "option_a": "left midbrain",
    "option_b": "Rt midbrain",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Other/Unclassified",
    "explanation": "The ocular tilt reaction (OTR) is a neuro-ophthalmologic syndrome characterized by a triad: skew deviation (vertical misalignment of the eyes), ocular torsion, and head tilt. In central lesions (i.e., those within the brainstem), the head tilt typically occurs contralateral to the lesion. In this scenario, a patient with left eye heterotropia (indicative of ocular misalignment/skew) and a head tilt to the right is suggestive of a lesion in the left midbrain. Lesions in the midbrain\u2014especially those affecting the vestibular pathways and structures like the interstitial nucleus of Cajal\u2014impair the proper processing of graviceptive signals. This disruption leads to an imbalance in how the brain perceives tilt relative to gravity, resulting in the ocular tilt reaction. In central lesions, the compensatory head tilt will be directed away from the affected side, hence a rightward tilt suggests a left-sided lesion. Patients exhibiting OTR often present with subtle signs that can be overlooked. A vertical misalignment (skew deviation) with head tilt should prompt consideration of brainstem pathology, including stroke, demyelination, or compressive lesions. Correctly localizing the lesion is critical, as central causes (midbrain or other brainstem regions) have different management strategies compared to peripheral vestibular disorders. The differential diagnosis for skew deviation and head tilt includes central causes such as brainstem stroke (especially in the midbrain or pons), demyelinating diseases, and sometimes tumors. Neuroimaging, particularly an MRI with attention to the brainstem, is essential. Peripheral vestibular lesions (like labyrinthine infarcts) can also cause similar findings but tend to produce an ipsiversive head tilt. A careful clinical evaluation alongside imaging helps in accurate localization. Management should focus on treating the underlying cause. For example, if an ischemic infarct is identified, stroke protocols including thrombolysis or secondary prevention measures may be indicated. In demyelination, disease-specific immunotherapy might be initiated. In all cases, it is important to address pregnancy and lactation considerations. For pregnant or lactating patients, the selection of imaging modalities (avoiding unnecessary contrast if possible) and medications (using those with established safety profiles) must be carefully considered as per current guidelines. Option A, which indicates a left midbrain lesion, corresponds with the expected contraversive head tilt seen in central ocular tilt reactions. A head tilt to the right implies the lesion is on the left side, making Option A the correct answer. The marked answer (Option B: right midbrain) would be appropriate in a scenario where a peripheral vestibular lesion is present, but not in the setting of a central brainstem lesion producing an OTR. Remember: In central lesions, particularly those affecting the midbrain, the head tilt accompanying an ocular tilt reaction is typically contralateral to the lesion. Thus, a head tilt to the right strongly suggests a lesion in the left midbrain. Recent neuro-ophthalmology studies and updated stroke guidelines have reinforced the value of ocular tilt reaction as a localizing sign. Advances in MRI have increased the sensitivity for detecting small brainstem lesions. Current clinical practice also emphasizes the importance of adapting management strategies for special populations, including pregnant or lactating women, by choosing safe imaging protocols and medications.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "A. Constipation\nB. Dysphagia\nC. Erectile dysfunction\nD. Hypothermia",
    "option_a": "Constipation",
    "option_b": "Dysphagia",
    "option_c": "Erectile dysfunction",
    "option_d": "Hypothermia",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Other/Unclassified",
    "explanation": "This question focuses on the recognition of non\u2010motor features in neurodegenerative disorders such as Parkinson\u2019s disease. Among the listed options, constipation is a well\u2010documented early symptom in Parkinson\u2019s disease and represents a key feature of autonomic dysfunction that can appear before classic motor signs. In Parkinson\u2019s disease, there is abnormal accumulation of alpha-synuclein in both the central nervous system and the enteric nervous system. This proteinopathy affects autonomic control, leading to impaired gastrointestinal motility. The resultant decrease in peristalsis manifests clinically as constipation, which may occur years before motor symptoms are evident. Patients may report chronic constipation long before developing tremors or rigidity. Recognizing constipation as a potential prodromal feature is important for clinicians, especially when it is seen along with other non-motor symptoms such as hyposmia or REM sleep behavior disorder. These non-motor manifestations can significantly impact quality of life and may provide critical early clues in making a diagnosis of Parkinson\u2019s disease. The diagnosis of Parkinson\u2019s disease is primarily clinical, supported by history and neurological examination. Differential diagnoses for constipation include metabolic conditions like hypothyroidism, irritable bowel syndrome, medication side effects, or other forms of dysautonomia. In cases where Parkinson\u2019s is suspected, additional evaluations (such as DaTscan imaging) might be used to confirm dopaminergic deficits in the basal ganglia. For constipation in Parkinson\u2019s disease, first-line treatment involves non-pharmacologic measures including increased dietary fiber, adequate hydration, and regular physical activity. If these are insufficient, osmotic laxatives such as polyethylene glycol are recommended. In pregnancy and lactation, non-pharmacologic measures are preferred to avoid fetal or neonatal exposure to medications; if pharmacologic intervention is necessary, agents with established safety profiles should be used under close supervision. Option A (Constipation) is correct because it is a common early non-motor symptom of Parkinson\u2019s disease. Option B (Dysphagia) often emerges later in the disease course as motor control worsens. Option C (Erectile dysfunction) can occur due to autonomic dysfunction but is less specific and not as early an indicator as constipation. Option D (Hypothermia) is not typically associated with the disease process in Parkinson\u2019s. 1. Constipation is often one of the earliest non-motor manifestations in Parkinson\u2019s disease and may precede motor symptoms by years. 2. Early recognition of non-motor symptoms can facilitate a timelier diagnosis and management strategy. 3. Lifestyle modifications remain the cornerstone of managing constipation in Parkinson\u2019s disease, with pharmacologic interventions added as needed. Recent research underscores the importance of the gut-brain axis in Parkinson\u2019s disease, suggesting that early gastrointestinal manifestations may serve as biomarkers for the disease. Updated clinical guidelines now emphasize comprehensive management of non-motor symptoms, as addressing these can significantly improve overall patient outcomes and quality of life.",
    "exam_year": "2018",
    "exam_type": "Promotion"
  },
  {
    "question": "Same scenario, what is the most important and useful way for investigation?",
    "option_a": "Brain MRI",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Critical Care Neurology",
    "explanation": "Brain MRI is a non-invasive imaging modality that provides excellent soft tissue contrast and resolution. It is the investigation of choice in many neurological conditions when detailed visualization of brain structures is needed. Many neurological disorders\u2014including inflammatory, demyelinating, neoplastic, and vascular pathologies\u2014alter tissue water content, myelination, and structure in ways best detected by MRI sequences such as T1, T2, FLAIR, and diffusion-weighted imaging. Updated protocols can identify subtle lesions that may be missed by CT. In cases where clinical symptoms (e.g., headache, focal neurological deficits, seizures) raise suspicion for conditions like multiple sclerosis, encephalitis, or even subtle ischemia, a brain MRI helps correlate clinical findings with structural abnormalities, guiding further management. Differential diagnoses in neurological presentations may include demyelinating diseases, tumors, vascular malformations, and infection. MRI differentiates these by lesion location, shape, enhancement patterns, and associated edema. Other imaging tests (like CT) are used for emergencies, but MRI offers superior detail in non-emergent contexts. Management is based on the underlying pathology. For example, in demyelinating disease, first\u2011line treatment involves high-dose steroids in relapses; in brain tumors, a multidisciplinary approach including neurosurgery, chemotherapy, and/or radiotherapy is used. In pregnant or lactating women, MRI is generally safe, though caution is advised with gadolinium contrast\u2014typically avoided unless absolutely necessary. Option A (Brain MRI) is correct because it offers the most detailed investigation for many neurological scenarios. The other options are not provided, so by process of elimination the best investigation in a scenario requiring detailed brain imaging is an MRI. 1. MRI is superior in visualizing soft tissue and is the investigation of choice for detailed brain pathology. 2. Always consider patient-specific factors such as pregnancy when selecting contrast agents. 3. In emergency settings, CT may be preferred due to speed, but MRI is ideal when time allows. Recent studies emphasize the superiority of MRI in detecting subtle brain lesions over CT. Newer MRI techniques and higher field strengths continue to improve diagnostic accuracy in neurology, and current guidelines underscore MRI\u2019s role in the diagnostic workup of non-emergent neurological presentations.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "Patient recently had a baby delivered by C-section one day ago, came to the ED with headache increases while sitting and coughing, brain MRI showed, neurological exam normal what will you do next?",
    "option_a": "LP",
    "option_b": "Blood patch",
    "option_c": "MRV",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Critical Care Neurology",
    "explanation": "Post-dural puncture headache (PDPH) is a well-recognized complication following neuraxial anesthesia (epidural or spinal) used during procedures such as cesarean sections. It is characterized by a positional headache that worsens when upright and improves when lying flat. PDPH arises due to a CSF leak from a dural tear caused by needle puncture. This leak results in decreased CSF pressure, leading to intracranial hypotension. The ensuing traction on pain-sensitive intracranial structures and compensatory cerebral vasodilatation results in the characteristic postural headache. MRI findings may include brain sagging and diffuse pachymeningeal enhancement. Patients typically present with a headache that worsens in the upright position and improves when supine. Other symptoms may include nausea, neck stiffness, and photophobia, while neurological examinations are usually normal. The clinical context (postpartum after C-section) supports the diagnosis of PDPH. Differentials include preeclampsia, migraine, tension-type headache, and cerebral venous thrombosis. In PDPH, brain MRI can help exclude more sinister causes and reinforce the diagnosis by displaying signs of CSF hypotension. A detailed history focusing on the temporal relation to dural puncture is key. Initial management is generally conservative, including bed rest, hydration, caffeine, and simple analgesics. However, an epidural blood patch is considered the definitive treatment for moderate to severe or refractory cases. It involves injecting autologous blood into the epidural space to seal the dural leak. In postpartum patients, an epidural blood patch is safe during lactation and does not compromise maternal care. Option A (LP) is contraindicated as performing another lumbar puncture may exacerbate the CSF leakage. Option B (Blood patch) is correct because it directly treats the underlying CSF leak and has a high success rate. Option C (MRV) is used to rule out cerebral venous thrombosis, but the clinical picture and confirmatory MRI findings point toward PDPH, making MRV less indicated in this scenario. 1. PDPH typically presents with a headache that worsens with upright posture. 2. An epidural blood patch is highly effective and considered the definitive treatment if symptoms are severe or persistent. 3. Conservative measures remain first-line unless the headache is debilitating. Recent guidelines and studies support the use of an epidural blood patch for moderate to severe PDPH after a trial of conservative management or when symptoms significantly impair function. Research continues to assess optimal timing and volume for the patch, with current evidence reaffirming its safety even in postpartum patients.",
    "exam_year": "2018",
    "exam_type": "Part I",
    "image_url": "https://drive.google.com/file/d/1N4i1NKERlA48DjJOUmAFc0ZkFHc5Ynva/preview"
  },
  {
    "question": "Female was in her house cleaning she fell down 3 meters, with severe headache and nausea, what will you do next:",
    "option_a": "Reassure and discharge",
    "option_b": "Observation in hospital",
    "option_c": "CT brain",
    "option_d": "",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Critical Care Neurology",
    "explanation": "In patients with head trauma, especially after falls from a significant height, prompt imaging is critical to identify intracranial injuries such as hemorrhages, contusions, or skull fractures. Traumatic brain injuries (TBIs) result from mechanical forces causing brain tissue damage. Falls from a height (3 meters in this case) can lead to rapid acceleration\u2013deceleration forces, resulting in brain contusion, intracranial hemorrhage, or diffuse axonal injury that manifest with severe headache and nausea. A severe headache and nausea following a fall are red flags for intracranial bleeding or other structural damage. The presence of these symptoms justifies immediate neuroimaging to rule out life-threatening conditions. Differential diagnoses include concussion, subdural hematoma, epidural hematoma, or skull fractures. CT brain is the modality of choice in acute trauma because it is fast, widely available, and highly sensitive for detecting acute hemorrhages and bony injuries. The first step in managing head trauma is stabilizing the patient followed by immediate neuroimaging. CT brain is essential for diagnosing acute hemorrhages that may require neurosurgical intervention. In pregnant patients, head CT is performed when necessary; fetal exposure in cranial CT is minimal, and protective measures (shielding) can be applied. Option A (Reassure and discharge) is incorrect given the mechanism of injury and symptoms. Option B (Observation in hospital) may delay the diagnosis of a potentially life-threatening injury. Option C (CT brain) is correct because it rapidly identifies intracranial pathology in the context of head trauma. 1. CT brain is the gold standard for evaluating acute head trauma. 2. A fall from significant height with severe headache warrants immediate imaging to exclude intracranial hemorrhage. 3. Nausea following trauma is a potential sign of increased intracranial pressure. Current guidelines continue to support the use of CT brain as the primary imaging modality in acute head injury due to its high sensitivity for acute hemorrhage. Advances in CT technology have improved speed and image quality, allowing for rapid decision-making in emergency settings.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "Patient with head trauma came to ED conscious and oriented after an hour he lost consciousness with dilated right pupil, what will you see in Brain CT:",
    "option_a": "Epidural hemorrhage",
    "option_b": "Subdural hemorrhage",
    "option_c": "Subarachnoid hemorrhage.",
    "option_d": "Lobar hemorrhage.",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Critical Care Neurology",
    "explanation": "Epidural hemorrhage is a form of traumatic intracranial hemorrhage that typically results from arterial bleeding, most often from a tear in the middle meningeal artery following skull fracture. After head trauma, a skull fracture can lacerate the middle meningeal artery, leading to rapid accumulation of blood between the dura mater and the inner table of the skull. This often creates a biconvex (lens-shaped) appearance on CT imaging. The classic clinical picture includes a lucid interval followed by rapid deterioration as the hematoma enlarges and exerts mass effect. Patients with epidural hematomas may initially appear well (conscious and oriented) and then rapidly deteriorate with signs of increased intracranial pressure such as loss of consciousness and unilateral pupil dilation (usually on the side of the hematoma). These findings are indicative of impending herniation, necessitating urgent intervention. Differential diagnoses include subdural hematoma (which typically appears crescent-shaped and results from slower venous bleeding), subarachnoid hemorrhage, and lobar hemorrhage from other etiologies like hypertension. CT scan is the investigation of choice as it characteristically shows a lens-shaped collection that does not cross suture lines. Management of epidural hematoma involves urgent neurosurgical consultation for possible surgical evacuation (typically via craniotomy). Stabilization of the patient and prompt management of raised intracranial pressure are imperative. In trauma cases involving pregnant or lactating patients, the same emergent neurosurgical interventions are applied with appropriate obstetric consultation to ensure maternal and fetal safety\u2014with fetal radiation exposure minimized by shielding when CT imaging is used. Option A (Epidural hemorrhage) is correct as it is the classic diagnosis associated with an initial lucid interval followed by rapid deterioration and signs of uncal herniation. Option B (Subdural hemorrhage) generally presents with a slower onset due to venous bleeding. Option C (Subarachnoid hemorrhage) typically presents with a sudden 'thunderclap' headache without an intervening lucid period. Option D (Lobar hemorrhage) is more associated with hypertensive bleeds rather than trauma. 1. A lucid interval followed by rapid deterioration is a hallmark of epidural hematoma. 2. CT imaging in epidural hematoma typically shows a biconvex, lens-shaped hemorrhage that does not cross suture lines. 3. Immediate neurosurgical intervention is crucial to reduce morbidity and mortality. Recent studies and updated trauma guidelines underscore the importance of rapid CT imaging and early surgical intervention in cases of epidural hematoma. Emerging research also focuses on refining criteria for surgical versus conservative management, but the presence of a mass effect with neurological deterioration remains an indication for prompt surgery.",
    "exam_year": "2018",
    "exam_type": "Part I",
    "image_url": "page_7.png"
  },
  {
    "question": "Patient with liver failure what will you see in EEG:",
    "option_a": "triphasic wave",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Critical Care Neurology",
    "explanation": "In patients with liver failure, hepatic encephalopathy is a common complication. The characteristic EEG finding in this metabolic encephalopathy is the presence of triphasic waves, which indicate diffuse cerebral dysfunction related to metabolic disturbances. Liver failure leads to an accumulation of toxins, such as ammonia, due to decreased hepatic clearance. These toxins alter neuronal activity and neurotransmitter balance, resulting in the distinctive triphasic wave pattern on EEG. This reflects the diffuse, generalized cerebral slowing and disruption in electrophysiologic activity. Clinically, patients with hepatic encephalopathy may present with confusion, altered mental status, asterixis, and other neurologic deficits. The appearance of triphasic waves on EEG supports the diagnosis and correlates with the severity of the encephalopathy. Diagnosis involves correlating clinical findings (e.g., altered mental status, labs showing elevated ammonia) with imaging and EEG studies. Differential diagnoses include uremic encephalopathy, anoxic brain injury, and other metabolic or toxic encephalopathies. EEG helps differentiate these conditions, as triphasic waves are most commonly associated with metabolic disturbances such as those seen in liver failure. Management focuses on lowering ammonia levels using agents like lactulose and rifaximin, along with supportive care. Although the EEG finding itself does not change management, it assists in monitoring disease progression. In pregnant or lactating patients, lactulose is generally considered safe. Rifaximin should be used cautiously, weighing potential risks and benefits due to limited pregnancy data. Option A (Triphasic wave) is correct because it directly correlates with the typical EEG findings in hepatic encephalopathy caused by liver failure. The other options are not provided, making A the correct and only applicable choice. 1. Triphasic waves on EEG are strongly associated with metabolic encephalopathies, particularly hepatic encephalopathy. 2. Clinical correlation with altered mental status and lab abnormalities (e.g., high ammonia) is essential for diagnosis. 3. Early recognition and management of hepatic encephalopathy can improve patient outcomes. Recent studies and clinical guidelines continue to validate the use of EEG as an ancillary tool in assessing hepatic encephalopathy, with triphasic waves remaining a hallmark of metabolic brain dysfunction in these patients.",
    "exam_year": "2018",
    "exam_type": "Part I",
    "image_url": "page_26.png"
  }
]